Delivery Order SPE2DB20D1109-SPE2DB24FP34R
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,605.44 firm-fixed-price contract is for the supply of 250 mg vials of the drug Ryanodex, with a completion date of July 2, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials. The contract has a ceiling value of $4,468.92 and a period of performance through September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by defense and civilian agencies to provide a wide range of essential...
- This is a $4,468.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 250mg vials of the pharmaceutical product Ryanodex, with a period of performance through October 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply medical commodities and prescription drugs to various military treatment facilities, veterans'...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 250 mg vials of the medication Ryanodex. The contract has a ceiling value of $2,979.28 and a period of performance through August 14, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA). The $2,979.28 firm-fixed-price contract has a completion date of July 11, 2024. This delivery order falls under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,816.32 by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, for the supply of Ryanodex 250mg vials. This firm fixed-price, non-set-aside contract is scheduled for completion by August 13, 2025, with performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical vendor supporting...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $9,632.64 firm fixed price delivery order is for RYANODEX 250 MG VIALS, a pharmaceutical product, with a performance period through July 15, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ryanodex 250 mg vials, with a ceiling value of $6,421.76 and a firm fixed price contract type. The award, which has no set-aside designation, is scheduled for completion by October 7, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order represents a discrete purchase under the broader federal pharmaceutical supply...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ryanodex 250mg vials with a firm fixed price ceiling value of $57,795.84 and an ultimate completion date of August 18, 2025. This is a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor with an...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,210.88 by the Defense Logistics Agency's Medical Supply Chain on May 14, 2025, for the supply of Ryanodex 250 mg vials. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 5, 2025. This delivery order is a child...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FP34RDelivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Ryanodex 250 mg vials, with a ceiling value of $1,489.64 and an ultimate completion date of July 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/14/24 |